Category: Cardiology/Vascular, Hematology, HIC#13883
Title:
A Safety and Efficacy Trial Evaluating the Use of Apixaban for the Extended Treatment of Deep Vein Thrombosis and Pulmonary Embolism (CV 185057)
Contact:Winsor Simmons Egolf
Phone:(434)243-0315
E-mail:wds5j@virginia.edu

UVa Health System, Department of Medicine Division of Hematology and Oncology seeks people over age 18 who have experienced a blood clot (also known as a deep vein thrombosis or pulmonary embolism) in the past 12 months and are currently taking blood thinner medications (anticoagulants) for a for research study.

This purpose of this study is to determine the risks and benefits of continued anticoagulation using the investigational drug, apixiban, following standard 6-12 months of anti-coagulation for the treatment of a DVT or PE.

The study involves taking an experimental medicine/placebo and 7-8 out-patient clinic visits and monthly phone contacts over the course of a year. The visits may include: blood draws, ECGs, physical exams, urine samples and pregnancy tests when applicable. Each visit is expected to last about 1 hour.

Study-related exams, tests and experimental medication provided free of charge.
Compensation for each completed study visit is $50. Total possible compensation for this study is $400.

Contact Information:
For more information please contact the Surgical Therapeutic Advancement Center at:
" Phone 434.243.0315
" Email: uvastac@virginia.edu
" IRB-HSR # 13883

Principal Investigator: B. Gail Macik, MD
Primary Investigator: Macik B. Gail,
Department: Internal Medicine
Division: Hematology/Oncology 		Accepts adult enrollment :YES
Accepts minor enrollment :NO